Takrozem 1 mg/g
Takrozem 1 mg/g is a medicine authorised by Swissmedic under authorisation number 67963. The authorisation holder is Pierre Fabre Pharma SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 December 2021 and the authorisation is valid without a time limit. ATC code D11AH01 places the medicine in the group Other dermatological preparations.
| Authorisation number | 67963 |
|---|---|
| Name | Takrozem 1 mg/g |
| Full name | Takrozem 1 mg/g, Salbe |
| Authorisation holder | Pierre Fabre Pharma SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | D11AH01 |
| First authorisation | 16 December 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Takrozem 1 mg/g, Salbe | B | 16 December 2021 |
| 2 | Takrozem 0,3 mg/g, Salbe | B | 28 November 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | g | D11AH01 | 10.04.0. | B |
| 2 | 30 | g | D11AH01 | 10.04.0. | B |
| 3 | 60 | g | D11AH01 | 10.04.0. | B |
| 4 | 10 | g | D11AH01 | 10.04.0. | B |
| 5 | 30 | g | D11AH01 | 10.04.0. | B |
| 6 | 60 | g | D11AH01 | 10.04.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Takrozem 1 mg/g authorised in Switzerland?
Yes. Takrozem 1 mg/g is authorised by Swissmedic under authorisation number 67963, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Takrozem 1 mg/g have?
Takrozem 1 mg/g is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Takrozem 1 mg/g?
The authorisation holder is Pierre Fabre Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.